Premature delivery associated with heightened risk of early death for mothers

▴ premature-delivery-need-long-term-clinical-follow-up
Several specific causes of death associated with preterm delivery were identified, including cardiovascular and respiratory disorders, diabetes, and cancer

Preterm and early term delivery are independent risk factors for premature death in women up to 40 years later, finds a study from Sweden published by The BMJ today.

These findings were not explained by shared genetic or early life environmental factors in families, suggesting that women who deliver prematurely “need long term clinical follow-up for detection and treatment of chronic disorders associated with early mortality,” say the researchers.

Nearly 11% of all deliveries worldwide occur preterm (before 37 weeks of pregnancy). Women who deliver preterm or extremely preterm (22-27 weeks) have been reported to have increased risks of developing conditions such as heart disease or diabetes in later life, but little is known about their long term risk of death.

So a team led by Professor Casey Crump at the Icahn School of Medicine at Mount Sinai in New York, set out to examine the long term mortality associated with preterm delivery in women, and to explore the potential influence of shared genetic or environmental factors within families.

Using nationwide birth records, they analysed data on length of pregnancy for over two million women who gave birth in Sweden during 1973-2015.

Deaths were then identified from the Swedish Death Register up to 31 December 2016 (a maximum follow-up time of 44 years).

Overall, 76,535 (3.5%) of women died, at an average age of 58.

After taking account of many other risk factors, the researchers found that women who delivered preterm or extremely preterm had 1.7-fold and 2.2-fold increased risk of death from any cause, respectively, during the next 10 years compared with those who delivered full term. This equates to around 28 excess deaths per 100,000 person years.

Whereas risks were highest in the first 10 years after delivery and then declined, absolute differences in death associated with preterm delivery increased with longer follow-up times.

For example, there was a 1.5-fold increased risk (equivalent to 48 excess deaths per 100,000 person years) 10-19 years after delivery, and a 1.4-fold increased risk (equivalent to 143 excess deaths per 100,000 person years) 20-44 years after delivery.

Overall, an estimated 2,654 excess deaths in this population were associated with preterm delivery (one excess death for every 73 women who delivered preterm).

Several specific causes of death associated with preterm delivery were identified, including cardiovascular and respiratory disorders, diabetes, and cancer. What’s more, these findings did not seem to be attributable to shared genetic or environmental factors within families.

This is an observational study so can’t establish cause, and the researchers acknowledge some limitations, such as a lack of complete information on spontaneous or medically indicated preterm delivery, and the fact that the results might not be applicable to other countries.

However, strengths included the large sample size and long follow-up time, prompting the researchers to say that premature delivery should now be recognised as a risk factor for early mortality in women that can remain raised up to 40 years later.

“Women who deliver prematurely need long term clinical follow-up for detection and treatment of chronic disorders associated with early mortality,” they conclude.

Tags : #PretermDelivery #ProfessorCaseyCrump #EarlyMortality #HeartDisease #Cancer #Diabetes

About the Author


Team Medicircle

Related Stories

26 Feb

Did the Government Force Covid Vaccines Without Responsibility? The Supreme Court Thinks So

Will the government take responsibility, or will affected families be left fighting a lonely legal battle? The coming weeks will determine the course of justice for those who lost loved ones in the fight against COVID-19.

View
23 Jan

Why India’s Vaccine Industry Struggles to Fund Innovation Despite Global Demand

Affordability ensures accessibility, but innovation determines its effectiveness. India, as a global leader in vaccine production, has a responsibility to balance these two aspects.

View
15 Nov

A Preventable Catastrophe: Why Are Children Still Dying from Measles?

Governments must step up their efforts, healthcare systems must become more resilient, and communities must rally together to protect their children.

View
09 Nov

The Deadly 17: WHO’s Vaccine Priority List to Tackle Life-Threatening Infections

By focusing on these 17 high-priority pathogens, WHO is leading the way for a world that is better prepared, more resilient, and healthier for all.

View
26 Sep

What Every Parent Needs to Know About Autism and Pandemic Babies

Contrary to earlier fears, the study found no connection between pandemic-related stress or maternal COVID-19 infection and a rise in autism rates among babies born during the pandemic.

View
06 Sep

The Complex Battle Against Polio: How India’s Vaccination Efforts Address Rare Vaccine-Derived Cases

Vaccine-derived poliovirus cases are extremely rare but can occur when the weakened strain of the poliovirus contained in the oral polio vaccine (OPV) mutates and regains its ability to cause disease.

View
16 Aug

A Giant Leap in India’s Fight Against Dengue: Phase 3 Vaccine Trial Launched

This trial not only aims to protect the population but also reinforces India’s capability to produce cutting-edge healthcare solutions, furthering the nation’s goal of self-reliance in essential medical innovations.

View
05 Aug

Lingering Shadows: The Unseen Battle with Long COVID

The study highlights the urgent need for continued research and development of effective treatments to alleviate the burden of long COVID on individuals and society.

View
31 Jul

COVID-19 Impact Resurfaces at Paris Olympics: Athletes Forced to Withdraw and Reinstated Precautions

The Paris Olympics, anticipated as the first post-pandemic Games, have faced unforeseen challenges due to a resurgence of COVID-19 cases among athletes.

View
30 Jul

Delhi High Court Orders Removal of Misleading Claims About Coronil by Baba Ramdev

Justice Bhambhani pointed out that promoting unverified claims about Coronil could harm the reputation of the ancient Ayurvedic system of medicine.

View

-Advertisements-




Trending Now

From Scroll to Squint: How Reels Are Reshaping Your VisionApril 02, 2025
Moscow Center for Diagnostics and Telemedicine Receives License for Radiology Residency ProgramApril 02, 2025
CARE Hospitals Launches AI-Powered Non-Invasive Therapy – An innovative modality introduced in Telangana & Andhra PradeshApril 02, 2025
High-Rise Heart Attacks: Are Skyscrapers Turning Survival into a Race Against Time?April 02, 2025
DCDC’s $150 Crore Expansion: Can Innovative Clinics End India's Kidney Crisis?April 02, 2025
Medanta Rolls Out ‘Colon Tunnel on Wheels’ to Drive Awareness on Colorectal Cancer Prevention & Early DetectionApril 01, 2025
Zigly launches 2 pet hospitals, opens 4 new stores; expects ARR to more than double in 1-2 yearsApril 01, 2025
University of Leeds Announces International Masters Regional Scholarships for 2025April 01, 2025
Avantor Recognized with Two Prestigious Awards at Asia-Pacific Biopharma Excellence Awards 2025April 01, 2025
Foundation Stone Laid for Madhav Netralaya Eye Hospital & Research CentreApril 01, 2025
Doomscrolling at Midnight: How Indians Are Sacrificing Sleep for ScreensMarch 31, 2025
Essential Medicines Price Surge: Are Patients Paying the Price?March 31, 2025
Prioritize your health during the holy days of RamzanMarch 31, 2025
Tired of Stomach Cramps? These Simple Foods Can Heal Your GutMarch 31, 2025
Regional growth booming for startups in 2024 - QBO Innovation studyMarch 31, 2025
Is long-acting HIV treatment as good as taking daily pills?March 31, 2025
Right to safe abortion cannot be dislocated from human rightsMarch 28, 2025
Popeyes® Opens Third Store in Hyderabad at Inorbit MallMarch 28, 2025
Popeyes® Opens Third Store in Hyderabad at Inorbit MallMarch 28, 2025
10 New HIV Cases in 2 Months: Has Kerala’s Drug Problem Gone Too Far?March 28, 2025